Article Versions Notes

Asperti M, Cantamessa L, Ghidinelli S, Gryzik M, Denardo A, Giacomini A, Longhi G, Fanzani A, Arosio P, Poli M. The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells. Pharmaceuticals. 2019; 12(3):129. https://doi.org/10.3390/ph12030129

Asperti, Michela, Luca Cantamessa, Simone Ghidinelli, Magdalena Gryzik, Andrea Denardo, Arianna Giacomini, Giovanna Longhi, Alessandro Fanzani, Paolo Arosio, and Maura Poli. 2019. "The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells" Pharmaceuticals 12, no. 3: 129. https://doi.org/10.3390/ph12030129

Asperti, M., Cantamessa, L., Ghidinelli, S., Gryzik, M., Denardo, A., Giacomini, A., Longhi, G., Fanzani, A., Arosio, P., & Poli, M. (2019). The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells. Pharmaceuticals, 12(3), 129. https://doi.org/10.3390/ph12030129